Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans

Correction to: Diabetologia

DOI: https://doi.org/10.1007/s00125-017-4479-9

The baseline insulin data given in Table 1 for the placebo group were incorrectly reported as 51 ± 10 pmol/l instead of 48 ± 10 pmol/l. This mistake also impacts on data reported in Table 4. The authors also note an error in the reported change in noradrenaline levels, from pre- to post-pioglitazone treatment (Table 4). The relevant rows from Tables 1 and 4 are reproduced here, with corrected data shown in bold. These corrections do not change the statistical significance of any comparison.

Table 1  Participant baseline characteristics
Table 4  Basal, fasting hormones, metabolites and lipids before and after the intervention

Author information

Correspondence to Bronwyn A. Kingwell or Andrew L. Carey.

Additional information

The online version of the original article can be found at https://doi.org/10.1007/s00125-017-4479-9

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Loh, R.K.C., Formosa, M.F., Eikelis, N. et al. Correction to: Pioglitazone reduces cold-induced brown fat glucose uptake despite induction of browning in cultured human adipocytes: a randomised, controlled trial in humans. Diabetologia 61, 504–505 (2018). https://doi.org/10.1007/s00125-017-4514-x

Download citation